Zosano Pharma
Zosano Pharma is a clinical-stage biopharmaceutical company specializing in the systemic administration of therapeutics using proprietary intracutaneous microneedle patch technology. The company aims to provide rapid, easy, and pain-free drug delivery options, including treatments for migraine and cluster headaches, with a focus on improving patient compliance and expanding therapeutic possibilities.
Industries
Nr. of Employees
small (1-50)
Zosano Pharma
Fremont, California, United States, North America
Products
Investigational intracutaneous zolmitriptan formulation for acute migraine and cluster headache
An investigational intracutaneous formulation of zolmitriptan delivered via a microneedle-array patch and reusable applicator designed to provide rapid systemic absorption for acute treatment of migraine and cluster headache.
Once-weekly parathyroid hormone patch (osteoporosis) - early development
A once-weekly parathyroid hormone formulation being developed for intracutaneous delivery as a potential osteoporosis treatment; program described for Phase 1 clinical development through commercialization partnerships.
Investigational intracutaneous zolmitriptan formulation for acute migraine and cluster headache
An investigational intracutaneous formulation of zolmitriptan delivered via a microneedle-array patch and reusable applicator designed to provide rapid systemic absorption for acute treatment of migraine and cluster headache.
Once-weekly parathyroid hormone patch (osteoporosis) - early development
A once-weekly parathyroid hormone formulation being developed for intracutaneous delivery as a potential osteoporosis treatment; program described for Phase 1 clinical development through commercialization partnerships.
Services
Platform partnering and co-development
Partnerships for co-development, licensing, commercialization, and lifecycle management using a transdermal microneedle patch platform across therapeutic and vaccine programs.
Platform partnering and co-development
Partnerships for co-development, licensing, commercialization, and lifecycle management using a transdermal microneedle patch platform across therapeutic and vaccine programs.
Expertise Areas
- Transdermal drug delivery
- Microneedle patch development
- Combination product (device + drug) development
- Clinical trial execution and pharmacokinetics
Key Technologies
- Intracutaneous microneedle arrays
- Drug-coated microneedles
- Reusable handheld applicator devices
- Room-temperature stable patch formulations